1:23-CV-00715
06/30/2023
Pending - Other Pending
Intellectual Property - Patent
William C. Bryson
Boehringer Ingelheim Pharmaceuticals Inc.
Boehringer Ingelheim International GmbH
Anobri Pharmaceuticals US, LLC
NanChang Anovent Pharmaceutical Co., Ltd.
Shanghai Anovent Pharmaceutical Co., Ltd.
Jack B. Blumenfeld
Anthony David Raucci
Main Document
Exhibit A-G
Civil Cover Sheet
(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 06/30/2023)
(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2023. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 11/19/2025. (apk) (Entered: 06/30/2023)
(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,284,474 B2 ;7,896,264 B2 ;7,396,341 B2 ;9,027,967 B2 ;7,837,235 B2 ;8,733,341 B2. (apk) (Entered: 06/30/2023)
(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (apk) (Entered: 06/30/2023)
Main Document
Summons Issued
Summons Issued
DocketCase Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-WCB, 1:23-cv-00716-WCB (rjb) (Entered: 07/10/2023)
[-] Read LessDocketCase Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:23-cv-00715-GBW, 1:23-cv-00716-GBW (rjb) (Entered: 07/05/2023)
[-] Read LessDocket(#6) Summons Issued as to Anobri Pharmaceuticals US, LLC on 6/30/2023; NanChang Anovent Pharmaceutical Co., Ltd. on 6/30/2023; Shaghai Anovent Pharmaceutical Co., Ltd. on 6/30/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(apk) (Entered: 06/30/2023)
[-] Read LessDocket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (apk) (Entered: 06/30/2023)
[-] Read LessDocket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,284,474 B2 ;7,896,264 B2 ;7,396,341 B2 ;9,027,967 B2 ;7,837,235 B2 ;8,733,341 B2. (apk) (Entered: 06/30/2023)
[-] Read LessDocket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/2023. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 11/19/2025. (apk) (Entered: 06/30/2023)
[-] Read LessDocket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 06/30/2023)
[-] Read LessDocket(#1) COMPLAINT filed against Anobri Pharmaceuticals US, LLC, NanChang Anovent Pharmaceutical Co., Ltd., Shaghai Anovent Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4170243.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(apk) (Entered: 06/30/2023)
[-] Read Less